SCHEMBL6947707

SCHEMBL6947707

COc1ccc(COc2c3c(nc(OS(=O)(=O)C(F)(F)F)c2[N+](=O)[O-])CCCCC3)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
POLB P06746 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HSD17B10 Q99714 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP19A1 P11511 2/20 0.36
CNR2 P34972 1/20 0.35
ACHE P22303 3/20 0.33
DCTPP1 Q9H773 2/20 0.33
TXNRD1 Q16881 2/20 0.33
PTPRZ1 P23471 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
BCHE P06276 2/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6952130 0.81 SMN1; SMN2 (0.36) SMN1; SMN2L3MBTL1ACHEBCHE
SCHEMBL8113406 0.80 SMN1; SMN2 (0.36) SMN1; SMN2L3MBTL1ACHEBCHE
SCHEMBL6953068 0.74 ACHE (0.33) SMN1; SMN2L3MBTL1ACHE
SCHEMBL6957441 0.73 HRH4 (0.42) ALDH1A1SMN1; SMN2ACHEDCTPP1CYP3A4
SCHEMBL8127299 0.71 MEN1 (0.35) ALDH1A1SMN1; SMN2L3MBTL1ACHEBCHE
SCHEMBL8122861 0.71 ACHE (0.36) ACHEBCHE
SCHEMBL8122765 0.70 ACHE (0.34) ALDH1A1SMN1; SMN2L3MBTL1ACHEBCHE
SCHEMBL8128249 0.70 ACHE (0.37) ACHEBCHE
SCHEMBL6954348 0.69 BCHE (0.40) ACHEBCHEHRH3
SCHEMBL8121921 0.68 ALDH1A1 (0.34) ALDH1A1POLBTSHRL3MBTL1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed